D-(−)-Isoascorbic acid
Molecular Structure:
MDL:
MFCD00005378
Molecular Formula:
C6H8O6
Molecular Weight:
176.12
Alias:
异抗坏血酸; 赤藻糖酸; 异维生素 C; D-2,3,5,6-四羟基-2-己烯酸-gamma-内酯
Product order:
| Name |
Specifications |
Packing |
Price |
Delivery |
| D-(−)-Isoascorbic acid |
≥99%, FCC, Kosher |
10kg |
RMB 2054.8 |
Consulting service |
| D-(−)-Isoascorbic acid |
≥99%, FCC, Kosher |
1kg |
RMB 314.6 |
Consulting service |
| D-(−)-Isoascorbic acid |
分析标准品 |
250mg |
RMB 423.5 |
Consulting service |
| D-(−)-Isoascorbic acid |
99% |
500g |
RMB 316.8 |
Consulting service |
| D-(−)-Isoascorbic acid |
99% |
100g |
RMB 94.6 |
Consulting service |
Character:
易溶于水(可溶解范围约30%)和醇。还原性强,暴露于光线或加热时逐渐变色(变黑)。干燥状态下稳定性强,但在水溶液中遇空气将很快分解。水溶性1g/10mL,,能溶于水、醇和吡啶,颇溶于丙醇,微溶于甘油,其化学性质与抗坏血酸非常相似,具有同样强的还原作用。
Quality Standard:
外观Appearance 白色至黄色粉末
红外光谱鉴别Infrared spectrometry 和对照匹配
纯度Purity ≥99.0% (碘量滴定)
熔点Melting point 164°C - 172°C
水溶解试验solubility in water 合格
比旋光度Specific rotation [a]20/D -16 ~ -19°(c = 10%, H2O)
Storage:
密封避光保存
用途 异抗坏血酸是维生素C的一种最重要的异构体。
Related Products
- 2,6-Dimethoxyphenylboronic acid
- 4-(Dimethylamino)cinnamic acid
- Salicylhydroxamic acid
- cis-4-Cyclohexene-1,2-dicarboxylic Acid
- Hexanoic acid
- 3,6,9-Trioxaundecanedioic acid
- Parabanic acid
- 1,3-Adamantanediacetic acid
- 4-(Trifluoromethoxy)benzoic acid
- Citrate
- 2-Amino-5-bromobenzoic acid
- ETHANOLAMINE HYDROCHLORIDE
- 3,3-Dimethylacrylic Acid
- 2-Methylpropanedioic acid
- 2,5-Difluorophenylboronic acid
- 5-Norbornene-2-carboxylic acid
- p-Toluenesulfonic acid
- 2,6-NAPHTHALENEDICARBOXYLIC ACID
- Hippuric acid
- 5-Hexynoic acid
- (S)-(-)-2-Amino-4-pentenoic acid hydrochloride
- Boc-3-(4-pyridyl)-D-Ala-OH
- Poly(methyl vinyl ether-alt-maleic acid)
- 3-Methylbenzo[b]thiophene-2-carboxylic acid
- 2,5-Dimethylphenylboronic acid
- 1-Bromo-2,5-dimethoxybenzene
- 2-Formylphenylboronic acid
- EGTA
- 4-Bromobenzoic aicd
- 2-Chloro-5-nitrobenzoic Acid
- 3-Phenylglutaric acid
- 3-(5-Ethyl-1,2,4-oxadiazol-3-yl)benzoic acid
- N-Glycolylneuraminic Acid
- Mevastatin
- 4-Methylcinnamic acid, predominantly trans
- L-(−)-Malic acid
- 3-Methylvaleric acid
- Boc-6-Ahx-OH
- 3-Methylphenyl-D-alanine
- Hexamethylenediamine-N,N,N',N'-tetrakis(methylphosphonic acid)
- Isotretinoin
- 1-Cyclohexene-1-carboxylic acid
- 2,4,5-Trimethoxybenzoic acid
- 4-Phenoxybenzoic Acid
- Levofloxacin carboxylic acid
- trans-2-Nitrocinnamic acid
- 1,2,3-Benzenetricarboxylic acid
- 2,3-Pyrazinedicarboxylic acid
- 4-[(2,4-Dimethoxyphenyl)(Fmoc-amino)methyl]phenoxyacetic acid
- 3-(Trifluoromethoxy)benzoic acid
- Triethylenetetramine-N,N,N',N'',N''',N'''-hexaacetic acid
- N-Acetylmuramic acid
- 3,3-Thiodipropionic acid
- Ginkgolic acid C17:1
- DL-4-Hydroxy-3-methoxymandelic acid
- 4-(5-Methyl-1,2,4-oxadiazol-3-yl)benzoic Acid
- Caffeic acid
- D-(−)-Quinic acid
- (±)-α-Methoxy-α-trifluoromethylphenylacetic acid
- (S)-(−)-2-Chloropropanoic acid
- 2-Fluoro-L-phenylalanine
- N-Phenylglycine
- (Z)-2-Amino-alpha-[1-(tert-butoxycarbonyl)]-1-1-methylethoxyimino-4-thiazolacetic acid
- Boc-Phe(2-Cl)-OH
- 2,4-Dinitrobenzenesulfonic acid hydrate
- 2-(Trifluoromethyl)acrylic acid
- 3-(Trifluoromethyl)cinnamic acid, predominantly trans
- 4-Acetoxybenzoic acid
- L-2-Aminobutyric acid
- Indole-5-carboxylic Acid
- 2-Iodophenylacetic acid
- 1-methyl-1H-indazole-3-carboxylic acid
- 3-Acetamidophenylboronic acid
- 3-exo-Aminobicyclo[2.2.1]hept-5-ene-2-exo-carboxylic acid
- Fmoc-β-Homomet-OH
- 2,5-Pyridinedicarboxylic acid
- Ellagic acid
- Isoquinoline-5-sulfonic Acid
- 4-(5-Ethyl-1,2,4-oxadiazol-3-yl)benzoic Acid
- (S)-(−)-2-Amino-4-pentenoic acid